1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Periódico
Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/76886
Full metadata record
DC FieldValueLanguage
dc.creatorJadison Luiz Barbosa Juniorpt_BR
dc.creatorPaulo Henrique Teixeira do Pradopt_BR
dc.creatorThales Pimenta de Figueiredopt_BR
dc.creatorCaio Hage Chahine Kubruslypt_BR
dc.creatorIzabela Maria Seabra Leitept_BR
dc.creatorLuiz Filipe Silva Cororino Coutopt_BR
dc.creatorPaulo Marcos Brasil Rochapt_BR
dc.date.accessioned2024-09-25T21:17:44Z-
dc.date.available2024-09-25T21:17:44Z-
dc.date.issued2023-
dc.citation.volume8pt_BR
dc.citation.issue3pt_BR
dc.identifier.doihttps://doi.org/10.30654/MJPMH.10042pt_BR
dc.identifier.issn2474-7564pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/76886-
dc.description.resumoCOVID-19 pandemic increased depression and anxiety worldwide and, although benzodiazepines are effective against acute anxiety, they are known to compromise respiratory physiology. Currently, however, no firm guidelines for benzodiazepine use in people with acute COVID-19 are available and there is sparse medical literature regarding benzodiazepine use in patients with active COVID-19 infection and acute anxiety symptoms. Therefore, we report in this correspondence a remarkable case regarding the parsimonious yet safe use of lorazepam for recurrent panic attacks during the course of active COVID-19 infection with severe acute respiratory syndrome. Benzodiazepines not only ceased panic attacks, but also improved respiratory parameters, as patient became less agitated and stopped manipulating his noninvasive ventilation devices. We further performed a narrative review of the literature, searching for studies regarding benzodiazepine use for acute anxiety in patients with COVID-19.pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE SAÚDE MENTALpt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofMathews Journal of Psychiatry & Mental Healthpt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectCovid-19pt_BR
dc.subjectAnxietypt_BR
dc.subjectPanicpt_BR
dc.subjectBenzodiazepinept_BR
dc.subjectRespiratorypt_BR
dc.subject.otherCovid-19pt_BR
dc.subject.otherAnsiedadept_BR
dc.subject.otherPânicopt_BR
dc.subject.otherBenzodiazepinaspt_BR
dc.titleThe use of benzodiazepines in the context of Coronavirus related severe acute respiratory syndrome: a case reportpt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://www.mathewsopenaccess.com/full-text/the-use-of-benzodiazepines-in-the-context-of-coronavirus-related-severe-acute-respiratory-syndrome-a-case-reportpt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-0944-5447pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-0337-1371pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-0600-9052pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-2314-8588pt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
The use of benzodiazepines in the context of Coronavirus related severe acute respiratory syndrome_ a case report.pdf146.39 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.